Laporan Laba Rugi 524731 - TTM - Jenburkt Pharmaceuticals Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Jenburkt Pharmaceuticals Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	1,118	1,100	1,093	1,190	1,241	1,252	1,240	1,279	1,283	1,298	1,367	1,348	1,372	1,383	1,420	1,453	1,483	1,495	1,517	1,547
Change (%)		-1.59	-0.65	8.92	4.22	0.95	-1.01	3.19	0.27	1.22	5.32	-1.43	1.81	0.80	2.63	2.37	2.01	0.83	1.47	1.97
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	308	307	308	336	334	323	322	322	319	319	339	323	328	322	313	321	312	309	308	311
Change (%)		-0.48	0.33	9.19	-0.59	-3.35	-0.38	0.20	-1.02	0.19	5.99	-4.73	1.75	-1.98	-2.58	2.39	-2.89	-0.86	-0.21	0.74
% of Revenue	27.56	27.87	28.15	28.22	26.92	25.77	25.93	25.18	24.86	24.61	24.76	23.93	23.92	23.26	22.08	22.08	21.02	20.67	20.32	20.08

Gross Operating Profit	810	793	785	855	907	930	918	957	964	979	1,029	1,025	1,044	1,062	1,116	1,132	1,171	1,186	1,209	1,236
Change (%)		-2.01	-1.03	8.81	6.11	2.54	-1.23	4.23	0.70	1.56	5.10	-0.34	1.83	1.67	5.09	1.51	3.40	1.28	1.91	2.29
% of Revenue	72.44	72.13	71.85	71.78	73.08	74.23	74.07	74.82	75.14	75.39	75.24	76.07	76.08	76.74	78.58	77.92	78.98	79.33	79.68	79.92

SG&A	346	340	324	329	341	353	365	370	380	388	388	393	401	412	425	435	451	445	455	466
Change (%)		-1.78	-4.64	1.68	3.65	3.42	3.40	1.42	2.59	2.17	0.03	1.29	2.07	2.76	3.05	2.36	3.74	-1.42	2.37	2.31
% of Revenue	30.92	30.86	29.62	27.65	27.50	28.18	29.43	28.93	29.60	29.88	28.38	29.16	29.24	29.81	29.93	29.93	30.43	29.76	30.02	30.12

R&D
Change (%)
% of Revenue

OpEx	933	910	915	964	983	995	985	1,007	1,028	1,044	1,086	1,069	1,089	1,098	1,112	1,122	1,129	1,127	1,140	1,175
Change (%)		-2.47	0.56	5.42	1.94	1.21	-0.97	2.17	2.07	1.62	3.95	-1.55	1.87	0.85	1.27	0.95	0.58	-0.22	1.20	3.09
% of Revenue	83.45	82.70	83.71	81.01	79.24	79.45	79.48	78.70	80.12	80.44	79.39	79.29	79.33	79.38	78.32	77.23	76.15	75.36	75.16	75.98

Operating Income	185	190	178	226	258	257	254	272	255	254	282	279	284	285	308	331	354	368	377	371
Change (%)		2.85	-6.43	26.91	13.94	-0.03	-1.19	7.12	-6.40	-0.41	10.98	-0.96	1.59	0.59	7.91	7.47	6.87	4.18	2.30	-1.42
% of Revenue	16.55	17.30	16.29	18.99	20.76	20.55	20.52	21.30	19.88	19.56	20.61	20.71	20.67	20.62	21.69	22.77	23.85	24.64	24.84	24.02

Interest Expense	-5	-4	-4	-4	-4	-4	-3	-3	-3	-3	-3	-3	-3	-2	-2	-3	-3	-4	-4	-4
Change (%)		-5.57	-4.14	-1.98	-3.46	-4.11	-9.56	-4.77	-4.71	0.70	-5.75	-4.24	-8.68	-12.55	0.31	17.83	17.64	12.55	5.97	-1.29
% of Revenue	-0.42	-0.40	-0.39	-0.35	-0.32	-0.31	-0.28	-0.26	-0.25	-0.24	-0.22	-0.21	-0.19	-0.17	-0.16	-0.19	-0.21	-0.24	-0.25	-0.24

Net Income	159	172	165	201	224	227	223	236	225	217	246	240	245	244	260	280	303	314	321	324
Change (%)		8.20	-4.29	22.07	11.41	1.25	-1.88	5.84	-4.68	-3.53	13.39	-2.37	1.90	-0.12	6.25	7.88	8.13	3.64	2.08	1.17
% of Revenue	14.25	15.67	15.10	16.92	18.09	18.14	17.98	18.45	17.54	16.71	17.99	17.82	17.84	17.68	18.30	19.28	20.44	21.01	21.14	20.97

Source: Capital IQ

Jenburkt Pharmaceuticals Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)